Aptose converts $1.5M debt into 409,063 shares at $3.70; amends investor rights with Hanmi

Aptose Biosciences Inc.

Converted $1,513,533.10 of debt owed to Hanmi into 409,063 common shares at $3.70 per share.
Interest for Dec. 21, 2024–Mar. 31, 2025 deferred; must be paid by June 27, 2025 to avoid default.
Amended investor rights: Hanmi gets demand and piggyback registration rights; can nominate employees if ownership ≥10%.
Company plans $15M capital raise; additional debt conversions allowed post-raise at Hanmi's discretion subject to 19.99% cap.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.